TIAM1 is an endogenous target of both miR-21 and miR-31. A, LIM 1863 organoids were treated with TGF-β/TNF-α (T+T) for 24 h and Western blotting was performed to determine TIAM1 levels (C16, Santa Cruz Biotechnology), with β-tubulin as a loading control. B and C, miR-21 and miR-31 down-regulate TIAM1 protein abundance in multiple colon cancer cell lines. LIM 1863 (B), DLD1 (C), or SW480 (C) cells were transfected with 100 nm miR-21 or miR-31 precursors, or a negative control precursor. After 72 h, TIAM1 protein level was measured by Western blotting. D, LIM 1863 cells were transfected with 100 nm indicated miRNA precursors and 48 h later, the levels of mature miR-21 and miR-31 were determined by the TaqMan miRNA assay (mean ± S.D., n>3). E, (left) Alignment of TIAM1 3′-UTR with the miR-21 sequence. The numbering starts from the first residue after the stop codon. Asterisks indicate the nucleotides that were mutated (CT->TG for both site 1 and site 2 mutations). (right), miR-21 directly targets the 3′-UTR of TIAM1. LIM 1863 cells were transfected first with 100 nm of miR-21 precursor or a control. Eighteen hours later the same cells were transfected with a Renilla luciferase reporter containing the wild type or mutant TIAM1 3′-UTR (e.g. S1: site 1 mutation; S2: site 2 mutation; S1/2: double mutation). A constitutively active firefly luciferase reporter was used as the internal control. The luciferase activities were measured and plotted (mean ± S.D., n>3). *, p < 0.05. F, Similar experiments as in E, analyzing the inhibitory impact of miR-31 on the 3′-UTR of TIAM1. The mutated TIAM1 3′-UTR residues are marked by * (CC->TT), the numbering is the same as in E. **, p < 0.05; ***, p < 0.001.